Ohuchi M, Yagishita S, Jo H, Akagi K, et al. Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients. Lung Cancer 2022;173:35-42.
PMID: 36116168